Recent studies have reported that serum TSP-2 amounts are moderately correlated with ballooning and fibrosis degree, and represent a potential prognostic molecular marker for clinical diagnosing NASH and advanced fibrosis in NAFLD [71,72,73]. Here, THBS2 is linked to metabolic dysfunction-associated steatotic liver disease.